MedPath

Modified Endotracheal Balloon Dilator to Improve Patient Oxygenation and Allow Ventilation During Airway Procedures

Not Applicable
Completed
Conditions
Tracheal Stenosis
Interventions
Device: improved tracheal balloon dilatation
Registration Number
NCT02796326
Lead Sponsor
University of Cape Town
Brief Summary

The purpose of the study is to prospectively assess the use of a modified tracheal balloon dilator that allows gas flow (oxygenation and ventilation) through the device while inflated during dilatation.

Detailed Description

The primary aim is to determine the incidence of, and time to, arterial desaturation (defined as peripheral plethysmography below 90%). Secondary aims include quantitative and qualitative (waveform) end-tidal capnography levels throughout the procedure, quantitative assessment of dilatation, and incidence of adverse events.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Age >18 years
  • Symptoms of tracheal or laryngeal stenosis or airway narrowing
  • Endoscopic evidence of subglottic or tracheal stenosis
  • Able to provide informed consent
Exclusion Criteria
  • Refractory stenosis not amenable to balloon dilatation
  • Contraindication to balloon dilatation
  • Lack of informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Dilatationimproved tracheal balloon dilatationPatients undergoing tracheal dilatation with the study device
Primary Outcome Measures
NameTimeMethod
Incidence of peripheral arterial desaturationDuring procedure (up to 60 minutes duration)

Incidence of desaturation below 90% as measured by peripheral pulse oximeter

Time to desaturationDuring procedure (up to 60 minutes duration)

Time to desaturation below 90% as measured by peripheral pulse oximeter

Secondary Outcome Measures
NameTimeMethod
Efficacy of tracheal dilatation by comparison of pre- and post-dilatation Myer-Cotton gradingDuring procedure (up to 60 minutes duration)

Describes the stenosis based on the percent relative reduction in cross-sectional area of the subglottis. Four grades of stenosis: grade I lesions have less than 50% obstruction, grade II lesions have 51% to 70% obstruction, grade III lesions have 71% to 99% obstruction, grade IV lesions have no detectable lumen or complete stenosis.

Incidence of major adverse eventsDuring and within 24 hours of procedure

Trial Locations

Locations (1)

Groote Schuur Hospital

🇿🇦

Cape Town, Western Cape, South Africa

© Copyright 2025. All Rights Reserved by MedPath